CD200-CD200R1 inhibitory signaling prevents spontaneous bacterial infection and promotes resolution of neuroinflammation and recovery after stroke

Abstract

Background Ischemic stroke results in a robust inflammatory response within the central nervous system. As the immune-inhibitory CD200-CD200 receptor 1 (CD200R1) signaling axis is a known regulator of immune homeostasis, we hypothesized that it may play a role in post-stroke immune suppression after stroke. Methods In this study, we investigated the role of CD200R1-mediated signaling in stroke using CD200 receptor 1-deficient mice. Mice were subjected to a 60-min middle cerebral artery occlusion and evaluated at days 3 and 7, representing the respective peak and early resolution stages of neuroinflammation in this model of ischemic stroke. Infarct size and behavioral deficits were assessed at both time points. Central and peripheral cellular immune responses were measured using flow cytometry. Bacterial colonization was determined in lung tissue homogenates both after acute stroke and in an LPS model of systemic inflammation. Results In wild-type (WT) animals, CD200R1 was expressed on infiltrating monocytes and lymphocytes after stroke but was absent on microglia. Early after ischemia (72 h), CD200R1-knockout (KO) mice had significantly poorer survival rates and an enhanced susceptibility to spontaneous bacterial colonization of the respiratory tract compared to wild-type (WT) controls, despite no difference in infarct or neurological deficits. While the CNS inflammation was resolved by day 7 post-stroke in WT mice, brain-resident microglia and monocyte activation persisted in CD200R1-KO mice, accompanied by a delayed, augmented lymphocyte response. At this time point, CD200R1-KO mice displayed greater weight loss, more severe neurological deficits, and impaired motor function compared to WT. Systemically, CD200R1-KO mice exhibited signs of persistent infection including lymphopenia, T cell activation and memory conversion, and narrowing of the TCR repertoire. These findings were confirmed in a second model of acute neuroinflammation induced by systemic endotoxin challenge. Conclusion This study defines an essential role of CD200-CD200R1 signaling in stroke. Loss of CD200R1 led to high mortality, increased rates of post-stroke infection, and enhanced entry of peripheral leukocytes into the brain after ischemia, with no increase in infarct size. This suggests that the loss of CD200 receptor leads to enhanced peripheral inflammation that is triggered by brain injury. Electronic supplementary material The online version of this article (10.1186/s12974-019-1426-3) contains supplementary material, which is available to authorized users.

Stroke Exacerbates Cancer Progression by Upregulating LCN2 in PMN-MDSC

“…Some of the alarmins could induce profound alterations of the peripheral immune system, leading to mobilization and even exhaustion of peripheral immune cells (28,29). Blocking the stroke-induced immune disturbance may not only attenuate ischemic brain injury, but also prevent poststroke infection (30). In the context of cancer-bearing stroke mice, the immune disturbance should exacerbate ischemic brain injury by paradoxical recruitment of immune suppressive cells into the tumor (11).…”

Delayed microglial depletion after spinal cord injury reduces chronic inflammation and neurodegeneration in the brain and improves neurological recovery in male mice

“…Resident microglia were identified as the CD45 int CD11b + Ly6C - population, and CNS-infiltrating leukocytes were identified as CD45 hi CD11b + myeloid cells or CD45 hi CD11b - lymphocytes. Within the CD45 hi myeloid subset, monocytes were identified as Ly6C hi Ly6G - and neutrophils, Ly6C + Ly6G + 55 (see Figure S1 ).…”

Interaction of microglia with infiltrating immune cells in the different phases of stroke

“…In fact, CD200 knockout mice present a stronger neuroinflammatory response after stroke with increased immune cell infiltration and microgliosis. This was associated with a worsened functional outcome at 7 days after stroke (93).…”